[Sociomedical aspects of detection and treatment of patients with tuberculosis under present conditions]. 1997

V V Punga, and A G Khomenko, and M B Stoiunin, and I D Danilova, and S I Kovaleva, and M P Zhukova, and T A Khudushina, and L N Rybka, and L P Alekseeva, and A N Starikov, and T A Grishina

By analyzing the present-day tuberculosis epidemiological situation in the country and sociomedical characteristics of new cases, the authors present methods for detecting and treating patients, which are of paramount importance for today. Of the most significance is the need to promptly identify patients with strains on their referral to the general somatic hospitals for complaints by using 3-multiple sputum bacterioscopy for Mycobacterium tuberculosis by the Ziehl-Neelsen method. The vital problem is also to change chemotherapeutical regimens as more severe progressive types of the disease require more active treatment in the first months after detection especially in the cohort of socially disadapted persons.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012426 Russia A country located in north Asia bordering the Arctic Ocean, extending from Europe (the portion west of the Urals) to the North Pacific Ocean. The capital is Moscow. Russian S.F.S.R.,Russian Federation (Europe),Russian SFSR

Related Publications

V V Punga, and A G Khomenko, and M B Stoiunin, and I D Danilova, and S I Kovaleva, and M P Zhukova, and T A Khudushina, and L N Rybka, and L P Alekseeva, and A N Starikov, and T A Grishina
December 1982, Pneumonologia polska,
V V Punga, and A G Khomenko, and M B Stoiunin, and I D Danilova, and S I Kovaleva, and M P Zhukova, and T A Khudushina, and L N Rybka, and L P Alekseeva, and A N Starikov, and T A Grishina
August 1978, Problemy tuberkuleza,
V V Punga, and A G Khomenko, and M B Stoiunin, and I D Danilova, and S I Kovaleva, and M P Zhukova, and T A Khudushina, and L N Rybka, and L P Alekseeva, and A N Starikov, and T A Grishina
January 1999, Problemy tuberkuleza,
V V Punga, and A G Khomenko, and M B Stoiunin, and I D Danilova, and S I Kovaleva, and M P Zhukova, and T A Khudushina, and L N Rybka, and L P Alekseeva, and A N Starikov, and T A Grishina
January 1993, Pneumoftiziologia : revista Societatii Romane de Pneumoftiziologie,
V V Punga, and A G Khomenko, and M B Stoiunin, and I D Danilova, and S I Kovaleva, and M P Zhukova, and T A Khudushina, and L N Rybka, and L P Alekseeva, and A N Starikov, and T A Grishina
January 1997, Problemy tuberkuleza,
V V Punga, and A G Khomenko, and M B Stoiunin, and I D Danilova, and S I Kovaleva, and M P Zhukova, and T A Khudushina, and L N Rybka, and L P Alekseeva, and A N Starikov, and T A Grishina
January 2015, Arkhiv patologii,
V V Punga, and A G Khomenko, and M B Stoiunin, and I D Danilova, and S I Kovaleva, and M P Zhukova, and T A Khudushina, and L N Rybka, and L P Alekseeva, and A N Starikov, and T A Grishina
January 2001, Problemy tuberkuleza,
V V Punga, and A G Khomenko, and M B Stoiunin, and I D Danilova, and S I Kovaleva, and M P Zhukova, and T A Khudushina, and L N Rybka, and L P Alekseeva, and A N Starikov, and T A Grishina
November 1978, Problemy tuberkuleza,
V V Punga, and A G Khomenko, and M B Stoiunin, and I D Danilova, and S I Kovaleva, and M P Zhukova, and T A Khudushina, and L N Rybka, and L P Alekseeva, and A N Starikov, and T A Grishina
January 1995, Problemy tuberkuleza,
V V Punga, and A G Khomenko, and M B Stoiunin, and I D Danilova, and S I Kovaleva, and M P Zhukova, and T A Khudushina, and L N Rybka, and L P Alekseeva, and A N Starikov, and T A Grishina
January 1999, Problemy tuberkuleza,
Copied contents to your clipboard!